| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 04/22/2008 | US7361783 Agonists for human PPAR alpha isoform; exhibit lipid-lowering effect, inhibitory effect on the arteriosclerosis, antiobesity effect, blood glucose-lowering effect; 2-{[3-(N-{[4-(3,5-bistrifluoromethylphenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenyl]methyl}butyric acid |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2302669C Piperidinylmethyloxazolidinone derivative |
| 04/17/2008 | WO2008043496A1 Method for producing bisbenzoxazoles |
| 04/17/2008 | WO2008002570B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | US20080091027 React azole derivative in hydrocarbon, ether solvent at mild temperaturein the presence of a catalytic iridium boron cyclooctadiene complex; intermediates to natural and synthetic functionalized compounds; cytotoxic, anticancer and antiviral agents |
| 04/17/2008 | US20080091025 Reduces the operating voltage and inhibits the molecules from being crystallized by using an aromatic amine derivative having a sulfur atom, an oxygen atom, a selenium atom, or a tellurium atom substituent for a hole transporting material; enhances yield in device, improves lifetime |
| 04/17/2008 | US20080091011 Novel crystalline form of linezolid |
| 04/17/2008 | US20080090884 Antimicrobial [3.1.0] bicyclohexylphenyl- oxazolidinone derivatives and analogues |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090824 Novel crystalline form of linezolid |
| 04/17/2008 | US20080090820 Novel crystalline form of linezolid |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | CA2666174A1 Method for producing bisbenzoxazoles |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910387A1 Compounds for preparing immunological adjuvant |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381426C Growth promotion method |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358368 Azlactone compound and method for preparation thereof |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/10/2008 | WO2008042497A2 Benzoxazole and benzothiazole compounds useful as authentication compounds in polymer articles |
| 04/10/2008 | WO2008040994A2 Fluoro-substituted benzoxazole polymethine dyes |
| 04/10/2008 | WO2008006044A3 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 04/10/2008 | WO2007126893A3 A convergent process for the synthesis of taxane derivatives |
| 04/10/2008 | CA2665324A1 Fluoro-substituted benzoxazole polymethine dyes |
| 04/09/2008 | CN101160295A 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 04/09/2008 | CN101160294A Anti-cancer and anti-microbial oxazolidinones and analogues |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/03/2008 | WO2008039587A1 Authenticatable polymer articles comprising benzoxazole and benzothiazole authentication compounds |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008017827A3 Azole and thiazole derivatives and their uses |
| 04/03/2008 | WO2008017816A3 Chemical compounds |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2007136672A3 Synthesis of a biaryl synthetic intermediate |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | US20080081913 Benzoxazole and benzothiazole compounds and methods therefor |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/02/2008 | EP1904465A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 04/02/2008 | EP1904439A2 Sphingosine kinase inhibitors |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN100378065C Synthesis of 2-chloromethyl-6-methylbenzoic ester |
| 04/01/2008 | US7351849 Process for producing optically active β-amino acid derivatives |
| 04/01/2008 | US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 04/01/2008 | US7351727 Inhibitors of 15-lipoxygenase |
| 03/27/2008 | WO2008035956A1 New benzoxazole derivative, process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/27/2008 | US20080076941 Optically active bisoxazoline compounds, process for production of the same and use thereof |
| 03/27/2008 | US20080076931 Optically active bisoxazoline compounds, process for production of the same and use thereof |
| 03/27/2008 | US20080076809 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses |
| 03/26/2008 | EP1902040A2 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 03/26/2008 | EP1902039A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 03/26/2008 | EP1901741A1 Process for synthesizing a cetp inhibitor |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/25/2008 | US7348436 Compounds useful for the synthesis of (+)-discodermolide and methods thereof |
| 03/25/2008 | US7348349 Oxazole derivatives |
| 03/25/2008 | US7348348 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/20/2008 | WO2008032191A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
| 03/20/2008 | WO2008031594A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | CA2660987A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 03/19/2008 | EP1900729A1 Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | CN101146781A Spirocyclic thrombin receptor antagonists |
| 03/19/2008 | CN101143854A Synthesis method for dibenzoxazole compounds |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/18/2008 | US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345067 peroxisome proliferator activators such as (2-methyl-4-{methyl-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethyl]-amino}-phenoxy)-acetic acid, used as lipid modulators and insulin sensitizers |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | US20080064887 Paclitaxel or docetaxel synthesis and claimed intermediates; purity; coupling 7,10-diprotected intermediates 7-O-(2-haloacyl)baccatin III or 7,10-O-di-(2-haloacyl)-10-deacetylbaccatin III to 3-[(2-alkyl/aryl-2-trialkylsilyl)ethoxy-carbonyl]-4-aryl-2-substituted-1,3-oxazolidine-5-carboxylic acid |
| 03/13/2008 | US20080064667 5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; effective against minocycline- and tetracycline-resistant bacteria |
| 03/12/2008 | EP1896135A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 03/12/2008 | EP1587799B1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/12/2008 | CN100374452C Transition metal complex having diphosphine complex as ligand |
| 03/12/2008 | CN100374428C Intermediary compounds for the hemisynthesis of taxanes and prepn. processes therefore |
| 03/11/2008 | US7342037 Anti-inflammatory medicaments |
| 03/11/2008 | US7342035 Process for preparing zolmitriptan compounds |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |